World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
32997
World Ranking
9323
National Ranking
4809

Overview

Jiaoti Huang is a researcher affiliated with Duke University in the United States. Their work spans medicine and biochemistry, genetics, and molecular biology, with significant contributions in pulmonary and respiratory medicine, molecular biology, cancer research, oncology, and radiology, nuclear medicine, and imaging.

The scientist's research topics prominently focus on prostate cancer treatment and research, prostate cancer diagnosis and treatment, cancer-related hypoxia and metabolism, radiopharmaceutical chemistry and applications, cancer lipids and metabolism, epigenetics and DNA methylation, and cancer-related gene regulation.

Among their recent publications are:

  • The DNA methylation landscape of advanced prostate cancer, 2020, Nature Genetics
  • The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer, 2020, Archives of Pathology & Laboratory Medicine
  • Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance, 2020, Proceedings of the National Academy of Sciences
  • LIN28B promotes the development of neuroendocrine prostate cancer, 2020, Journal of Clinical Investigation
  • Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma, 2024, New England Journal of Medicine

Huang frequently publishes in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), and Archives of Pathology & Laboratory Medicine.

The scientist collaborates regularly with several co-authors, including Rahul Aggarwal, Eric J. Small, Martin Gleave, Andrew J. Armstrong, and Qianben Wang, with collaboration counts ranging from 14 to 16 joint publications each.

Huang has also contributed to book publications, such as the title Ferroptosis as New Therapeutic Targets in Cancer: from Molecular Mechanisms to Therapeutic Opportunities, published in 2022 by Frontiers Media.

Best Publications

  • The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

    John R. Srigley;Brett Delahunt;John N. Eble;Lars Egevad

  • Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation.

    T. Spivak-Kroizman;M.A. Lemmon;I. Dikic;J.E. Ladbury

  • The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters

    Brett Delahunt;John C. Cheville;Guido Martignoni;Peter A. Humphrey

  • Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers.

    Shutao Wang;Kan Liu;Jian Liu;Jian Liu;Zeta T.-F. Yu

  • Identification of a Cell of Origin for Human Prostate Cancer

    Andrew S. Goldstein;Jiaoti Huang;Changyong Guo;Isla P. Garraway

  • Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation.

    Wolfgang Vogel;Reiner Lammers;Jiaoti Huang;Axel Ullrich

  • Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.

    David A. Quigley;Ha X. Dang;Shuang G. Zhao;Paul Lloyd

  • Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study

    Rahul Aggarwal;Jiaoti Huang;Joshi J. Alumkal;Li Zhang

  • Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth

    David J. Mulholland;Linh M. Tran;Yunfeng Li;Houjian Cai

  • PC3 is a cell line characteristic of prostatic small cell carcinoma.

    Sheng Tai;Yin Sun;Jill M. Squires;Hong Zhang;Hong Zhang

  • Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

    David J. Mulholland;Naoko Kobayashi;Marcus Ruscetti;Allen Zhi

  • Multifocality and Prostate Cancer Detection by Multiparametric Magnetic Resonance Imaging: Correlation with Whole-mount Histopathology

    Jesse D. Le;Nelly Tan;Eugene Shkolyar;David Y. Lu

  • Value of Targeted Prostate Biopsy Using Magnetic Resonance–Ultrasound Fusion in Men with Prior Negative Biopsy and Elevated Prostate-specific Antigen

    Geoffrey A. Sonn;Edward Chang;Shyam Natarajan;Daniel J. Margolis

  • Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies

    Christopher P. Filson;Shyam Natarajan;Daniel J.A. Margolis;Jiaoti Huang

  • Aggressive Variants of Castration-Resistant Prostate Cancer

    Himisha Beltran;Scott A. Tomlins;Ana M. Aparicio;Vivek K Arora

  • Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance

    Hiroshi Tanaka;Evelyn Kono;Chau P Tran;Hideyo Miyazaki

  • The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

    Jichao Qin;Xin Liu;Xin Liu;Brian Laffin;Xin Chen;Xin Chen

  • Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer.

    Shancheng Ren;Yawei Liu;Weidong Xu;Yi Sun

  • N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells

    John K. Lee;John W. Phillips;Bryan A. Smith;Jung Wook Park

  • Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer

    Shancheng Ren;Fubo Wang;Jian Shen;Yi Sun

Frequent Co-Authors

Robert E. Reiter
Robert E. Reiter University of California, Los Angeles
Owen N. Witte
Owen N. Witte University of California, Los Angeles
Martin E. Gleave
Martin E. Gleave University of British Columbia
Eric J. Small
Eric J. Small University of California, San Francisco
Tomasz M. Beer
Tomasz M. Beer Oregon Health & Science University
George Thomas
George Thomas Oregon Health & Science University
Frederick J. Dorey
Frederick J. Dorey University of California, Los Angeles
Liang Cheng
Liang Cheng Brown University
Primo N. Lara
Primo N. Lara University of California, Davis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare, but considering an alternative path to medical school? There are a variety of flexible online degree programs that prepare students for rewarding roles in the health sector. For those with a passion for leadership in clinical and non-clinical settings, an online healthcare management degree is an excellent option. This pathway develops critical skills in policy, finance, and hospital administration.

Registered nurses seeking to advance their clinical expertise may consider adn to fnp bridge programs, which provide a direct path to becoming a Family Nurse Practitioner. Online learning is also a great fit for those interested in nutrition and wellness. An online nutrition degree helps students learn about dietetics, health promotion, and disease prevention.

For aspiring healthcare executives, many universities now offer online mha programs with CAHME accreditation, ensuring rigorous preparation for leadership roles. These online options provide flexibility, allowing diverse learners to pursue specialized healthcare careers while balancing work and family commitments.

Best Scientists Citing Jiaoti Huang

Trending Scientists

Recently Published Articles